| Atovaquone‐proguanil vs | No. trials | No. participants | Risk ratio | 95% confidence interval | Location | Trial |
| Chloroquine | 1 | 27 | 0.04 | 0.00 to 0.57 | Peru | Llanos‐Cuentas 2001 |
| Amodiaquine | 2 | 342 | 0.22 | 0.13 to 0.36 | Gabon | Borrmann 2003, Radloff 1996 |
| Sulfadoxine‐pyrimethamine | 2 | 172 | 0.33 | 0.01 to 8.06 | Peru, Zambia | Llanos‐Cuentas 2001, Mulenga 1999 |
| Quinine plus tetracycline | 1 | 154 | 3.00 | 0.12 to 72.52 | Brazil | De Alencar 1997 |
| Halofantrine | 2 | 205 | 0.64 | 0.22 to 1.88 | Kenya, France | Anabwani 1999, Bouchaud 2000 |
| Mefloquine | 1 | 158 | 0.04 | 0.00 to 0.73 | Thailand | Looareesuwan 1999a |
| Artesunate plus mefloquine | 1 | 1063 | 1.11 | 0.47 to 2.58 | Thailand | Van Vugt 2002 |
| Dihydroartemisinin‐piperaquine‐trimethoprim‐primaquine | 1 | 161 | 1.25 | 0.40 to 3.92 | Vietnam | Giao 2004 |